Skip to content

Preventive effect of tamsulosin on postoperative urinary retention in benign ?perianal surgeries

Preventive effect of tamsulosin on postoperative urinary retention in benign ?perianal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016122720258N22
Enrollment
243
Registered
2017-01-04
Start date
2016-06-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign perianal surgeries. Benign neoplasm of urinary organs

Interventions

Intervention 1: Intervention group: We prescribe 0.4 milligram Tamsulosin one dose in 6 hours before surgery in 81 patient. Intervention 2: Intervention group: We prescribe 0.4 milligram Tamsulosin
Treatment - Drugs
Intervention group: We prescribe 0.4 milligram Tamsulosin one dose in 6 hours before surgery in 81 patient.
Intervention group: We prescribe 0.4 milligram Tamsulosin one dose in 6 hours before surgery and 6 hours after surgery in 81 patient.
Control group: We prescribe Placebo seems intervention group in 81 patient.

Sponsors

Vice chancellor for research, Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-50 years; Indications for surgery hemorrhoidectomy; sphincterotomy; incisions; perianal abscess drainage and fistulatomy and fistulectomy Exclusion criteria: active urinary tract infection; history of neurological disorders; malignancy; urinary incontinence; use of drugs affecting the performance of urination; urology disorder; prostate cancer; bladder cancer; history of urinary stones or urinary obstruction; benign prostatic hypertrophy; history of urology surgery; urinary catheter fixed; chronic kidney disease; cardiopulmonary disorders; history of allergy to Tamsulosin; history of treatment and use Tamsulosin.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Urinary retention. Timepoint: 24 hour after surgery. Method of measurement: clinical response.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Cyrus

Arak University of Medical Sciences

cyrus@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026